Narrative review / 2021
An expert consensus report defined type 2 diabetes remission as HbA1c <6.5% at least 3 months after stopping glucose-lowering drugs.
An international expert group convened by the American Diabetes Association met to propose standardized nomenclature and objective measures for sustained glucose improvement in type 2 diabetes. The group proposed 'remission' as the most appropriate term and suggested HbA1c <6.5% (48 mmol/mol) measured at least 3 months after cessation of glucose-lowering pharmacotherapy as the usual diagnostic criterion. Recommendations were also provided for active observation of patients experiencing remission and for addressing unmet needs regarding predictors and outcomes.
- Study type
- Consensus report
- Who was studied
- People living with type 2 diabetes
- What was measured
- Definition, nomenclature, diagnostic criteria, and data collection principles for remission in type 2 diabetes
THE PAPER
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, Rothberg AE, le Roux CW, Rubino F, Schauer P, Taylor R, Twenefour D. Diabetes Care, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.